Enanta Pharmaceuticals (ENTA) Capital Expenditures Growth (3y) (2015 - 2026)
Enanta Pharmaceuticals (ENTA) Capital Expenditures Growth (3y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Enanta Pharmaceuticals |
365.48 Mn |
201.71 Mn |
- |
-81.54% |
| Date | Value |
|---|
| Mar 31, 2026 |
-81.54% |
| Dec 31, 2025 |
-64.35% |
| Sep 30, 2025 |
179.44% |
| Jun 30, 2025 |
-245.91% |
| Mar 31, 2025 |
86.54% |
| Dec 31, 2024 |
475.00% |
| Sep 30, 2024 |
150.46% |
| Jun 30, 2024 |
147.25% |
| Mar 31, 2024 |
134.11% |
| Dec 31, 2023 |
61.17% |
| Sep 30, 2023 |
142.86% |
| Jun 30, 2023 |
124.54% |
| Mar 31, 2023 |
102.37% |
| Dec 31, 2022 |
86.31% |
| Sep 30, 2022 |
21.20% |
| Jun 30, 2022 |
-51.72% |
| Mar 31, 2022 |
-37.31% |
| Dec 31, 2021 |
-67.20% |
| Sep 30, 2021 |
157.48% |
| Jun 30, 2021 |
36.65% |
